| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A999017 | Anti-PCSK9 Reference Antibody (ebronucimab), Anti-PCSK9 Reference Antibody (ebronucimab), |
|||
| A999018 | Anti-PCSK9 Reference Antibody (evolocumab), Anti-PCSK9 Reference Antibody (evolocumab), |
|||
| A999019 | Anti-PCSK9 Reference Antibody (frovocimab), Anti-PCSK9 Reference Antibody (frovocimab), |
|||
| A999020 | Anti-PCSK9 Reference Antibody (lodelcizumab), Anti-PCSK9 Reference Antibody (lodelcizumab), |
|||
| A999021 | Anti-PCSK9 Reference Antibody (Merck patent anti-PCSK9), Anti-PCSK9 Reference Antibody (Merck patent anti-PCSK9), |
|||
| A999022 | Anti-PCSK9 Reference Antibody (ongericimab), Anti-PCSK9 Reference Antibody (ongericimab), |
|||
| A999023 | Anti-PCSK9 Reference Antibody (ralpancizumab), Anti-PCSK9 Reference Antibody (ralpancizumab), |
|||
| A999024 | Anti-PCSK9 Reference Antibody (recaticimab), Anti-PCSK9 Reference Antibody (recaticimab), |
|||
| A999025 | Anti-PCSK9 Reference Antibody (RG7652), Anti-PCSK9 Reference Antibody (RG7652), |
|||
| A999026 | Anti-PCSK9 Reference Antibody (Schering patent anti-PCSK9), Anti-PCSK9 Reference Antibody (Schering patent anti-PCSK9), |
|||
| A999027 | Anti-PCSK9 Reference Antibody (tafolecimab), Anti-PCSK9 Reference Antibody (tafolecimab), |
|||
| A666790 | Anti-PD-1 & CTLA-4 Reference Antibody (Cadonilimab), Target:PD-1&CTLA-4,Uniprot:Q15116&P16410,Species:Human,isotype:IgG-scFv Anti-PD-1 & CTLA-4 Reference Antibody (Cadonilimab), Target:PD-1&CTLA-4,Uniprot:Q15116&P16410,Species:Human,isotype:IgG-scFv |
|||
| A666739 | Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab), Target:PD-1&PD-L1,Uniprot:Q15116&Q9NZQ7,Species:Human,isotype:IgG-like Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab), Target:PD-1&PD-L1,Uniprot:Q15116&Q9NZQ7,Species:Human,isotype:IgG-like |
|||
| A666783 | Anti-PD-1 & TIGIT Reference Antibody (Rilvegostomig), Target:PD-1&TIGIT,Uniprot:Q15116&Q495A1,Species:Human,isotype:IgG-like Anti-PD-1 & TIGIT Reference Antibody (Rilvegostomig), Target:PD-1&TIGIT,Uniprot:Q15116&Q495A1,Species:Human,isotype:IgG-like |
|||
| A666724 | Anti-PD-1 & TIM-3 Reference Antibody (Lomvastomig), Target:PD-1&TIM-3,Uniprot:Q15116&Q8TDQ0,Species:Human,isotype:IgG-like Anti-PD-1 & TIM-3 Reference Antibody (Lomvastomig), Target:PD-1&TIM-3,Uniprot:Q15116&Q8TDQ0,Species:Human,isotype:IgG-like |
|||
| A666738 | Anti-PD-1 & VEGF Reference Antibody (Ivonescimab), Target:PD-1&VEGF,Uniprot:Q15116&P15692,Species:Human,isotype:IgG-scFv Anti-PD-1 & VEGF Reference Antibody (Ivonescimab), Target:PD-1&VEGF,Uniprot:Q15116&P15692,Species:Human,isotype:IgG-scFv |
|||
| A666780 | Anti-PD-L1 & TGF-β Reference Antibody (Tqb2858), Target:PD-L1&TGF-β,Uniprot:Q9NZQ7&P01137,Species:Human,isotype:IgG-VHH Anti-PD-L1 & TGF-β Reference Antibody (Tqb2858), Target:PD-L1&TGF-β,Uniprot:Q9NZQ7&P01137,Species:Human,isotype:IgG-VHH |
|||
| A666789 | Anti-PD-L1 & VEGF Reference Antibody (Pm8002), Target:PD-L1&VEGF,Uniprot:Q9NZQ7&P15692,Species:Human,isotype:IgG-VHH Anti-PD-L1 & VEGF Reference Antibody (Pm8002), Target:PD-L1&VEGF,Uniprot:Q9NZQ7&P15692,Species:Human,isotype:IgG-VHH |
|||
| A666781 | Anti-PD-L1 & VEGF Reference Antibody (Sotiburafusp alfa), Target:PD-L1&VEGF,Uniprot:Q9NZQ7&P15692,Species:Human,isotype:IgG-FusionProtein Anti-PD-L1 & VEGF Reference Antibody (Sotiburafusp alfa), Target:PD-L1&VEGF,Uniprot:Q9NZQ7&P15692,Species:Human,isotype:IgG-FusionProtein |
|||
| A999028 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (balstilimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (balstilimab), |